ARCHIVES

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

High Cervical Cancer Rates Indicate Access Problems

August 26, 2005

Patient Advocacy: Prostate Cancer coalition Is Formed

September 6, 1996

Agency Approves HPV Test That Detects 14 High-Risk Strains

November 25, 2011

Coffey Presses NCI BSA chairman David Linvingston On support For Increase In NCI Budget

April 25, 1997

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006

In Brief: ONS Lectures Announced; Brennan To Retire As Michigan Cancer Foundation President

April 19, 1991